Related Experiment Video
Updated: May 14, 2025

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
Published on: January 26, 2024
TransABseq: A Two-Stage Approach for Predicting Antigen-Antibody Binding Affinity Changes upon Mutation Based on
Cui-Feng Li1, Zihao Yan2, Fang Ge3
1School of Computer, Jiangsu University of Science and Technology, 666 Changhui Road, Zhenjiang 212100, China.
The antigen-antibody interaction represents a critical mechanism in host defense, contributing to pathogen neutralization, tumor surveillance, immunotherapy, and in vitro disease detection. Owing to their exceptional specificity, affinity, and selectivity, antibodies have been extensively utilized in the development of clinical diagnostic, therapeutic, and prophylactic strategies. In this study, we propose TransABseq, a novel computational framework specifically designed to predict the effects of missense mutations on antigen-antibody interactions. The model's innovative two-stage architecture enables comprehensive feature analysis: in the first stage, multiple embeddings of protein language models are processed through a Transformer encoder module and a multiscale convolutional module; in the second stage, the XGBOOST model is used to perform quantitative output based on the deeply fused features. A critical advancement contributing to the effectiveness of TransABseq is the deep feature fusion strategy, which reveals the biochemical properties of proteins. By leveraging the multilayer self-attention mechanism of the Transformer to capture complex global dependencies within sequences and mining features at different hierarchical levels through multiscale convolution, the feature abstraction capability of TransABseq is significantly enhanced. We evaluated TransABseq through three distinct cross-validation strategies on two established benchmarks and a newly reconstructed data set. As a result, TransABseq achieved average PCC values of 0.607, 0.843, and 0.794 and average RMSE values of 1.166, 1.314, and 1.337 kcal/mol in 10-fold cross-validation. Furthermore, its robustness and predictive accuracy were validated on blind test data sets, where TransABseq outperformed existing methods, enabling it to attain a PCC of 0.721 and an RMSE of 0.925 kcal/mol. The relevant data and code have been made publicly available for academic research at: https://github.com/cuifengLI/TransABseq.
The antigen-antibody interaction represents a critical mechanism in host defense, contributing to pathogen neutralization, tumor surveillance, immunotherapy, and in vitro disease detection. Owing to their exceptional specificity, affinity, and selectivity, antibodies have been extensively utilized in the development of clinical diagnostic, therapeutic, and prophylactic strategies. In this study, we propose TransABseq, a novel computational framework specifically designed to predict the effects of missense mutations on antigen-antibody interactions. The model's innovative two-stage architecture enables comprehensive feature analysis: in the first stage, multiple embeddings of protein language models are processed through a Transformer encoder module and a multiscale convolutional module; in the second stage, the XGBOOST model is used to perform quantitative output based on the deeply fused features. A critical advancement contributing to the effectiveness of TransABseq is the deep feature fusion strategy, which reveals the biochemical properties of proteins. By leveraging the multilayer self-attention mechanism of the Transformer to capture complex global dependencies within sequences and mining features at different hierarchical levels through multiscale convolution, the feature abstraction capability of TransABseq is significantly enhanced. We evaluated TransABseq through three distinct cross-validation strategies on two established benchmarks and a newly reconstructed data set. As a result, TransABseq achieved average PCC values of 0.607, 0.843, and 0.794 and average RMSE values of 1.166, 1.314, and 1.337 kcal/mol in 10-fold cross-validation. Furthermore, its robustness and predictive accuracy were validated on blind test data sets, where TransABseq outperformed existing methods, enabling it to attain a PCC of 0.721 and an RMSE of 0.925 kcal/mol. The relevant data and code have been made publicly available for academic research at: https://github.com/cuifengLI/TransABseq.
Related Concept Videos
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Mutations
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
Protein-protein Interfaces

